γH2AX: Applications for the evaluation of telomerase-based cancer therapy.
Nakamura
Asako J
AJ
Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. nakamuraa@mail.nih.gov
Redon
Christophe E
CE
Bonner
William M
WM
D017209:Apoptosis; D053903:DNA Breaks, Double-Stranded; D006657:Histones / Q000032:analysis* / Q000378:metabolism; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017382:Reactive Oxygen Species / Q000378:metabolism; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000378:metabolism
C468783:H2AX protein, human; D006657:Histones; D017382:Reactive Oxygen Species; D019098:Telomerase